Tidepath Get an early invite

Free tools · Semaglutide and tirzepatide

How your GLP-1 level builds, settles and fades

 of the weekly high ·

The same dose every week, from the first shot. Slide along the curve. An estimate of how much medicine is left from doses taken, not a blood level.

See the numbers

Keep your shots, food and training in one place.

In the Tidepath app, this curve is drawn from the doses you log, next to your meals and workouts. It isn't in the App Store yet. Leave your email for an early invite, and tips for your first month.

One list, about Tidepath only. Unsubscribe anytime. See how the app works

How this is calculated

Each weekly dose is counted in full on shot day, then halves every half-life: 7 days for semaglutide, 5.5 days for tirzepatide. The curve adds up what's left of every dose so far. It's the same calculation the Tidepath app uses.

100% is the weekly high once the level has settled. Nothing is shown in milligrams, because for one steady weekly dose the shape is the same at any amount. That's also why the tool never asks what dose you take.

What it leaves out

  • Absorption. A real level peaks a day or more after the shot, not on it, and swings less sharply.
  • You. People clear these medicines at different rates.
  • Dose changes, and late or missed weeks. It draws one steady dose.
  • Tablets, compounded products and other peptides. It covers the once-weekly injections with a half-life on an FDA label.

Sources

Last reviewed

Questions about levels and half-lives

How long does semaglutide (Ozempic, Wegovy) stay in your system?

Semaglutide stays in the body for about 5 weeks after the last dose, according to the Ozempic label; the Wegovy label says about 5 to 7 weeks after the last injection.

More detail and sources

Both labels give semaglutide a half-life of about 1 week. A half-life is the time it takes for half of what's there to clear, so the amount halves each week. By that arithmetic, about 3% of the last weekly high is left after 5 weeks, and under 1% after 7.

The labels' own words: Ozempic's says “With an elimination half-life of approximately 1 week, semaglutide will be present in the circulation for about 5 weeks after the last dose.” Wegovy's says “about 5 to 7 weeks after the last injectable dose of 2.4 mg or 7.2 mg or oral dose of 25 mg.”

These figures are about the medicine itself. They don't say how long its effects are felt, and this tool can't estimate that.

How long does tirzepatide (Mounjaro, Zepbound) stay in your system?

Tirzepatide has a half-life of about 5 days, and its maker, Eli Lilly, says it should be gone from the body about 30 days after the last dose (Lilly medical information for Zepbound).

More detail and sources

The Mounjaro label gives the half-life as “approximately 5 days” and the Zepbound label as “approximately 5-6 days”. Unlike the semaglutide labels, neither gives a number of weeks in the circulation.

By the arithmetic of half-lives, using the 5.5 days this tool works with, about 3% of the last weekly high is left after 4 weeks and about 2% after 30 days.

What is the half-life of Ozempic, Wegovy, Mounjaro and Zepbound?

About 1 week for Ozempic and Wegovy, about 5 days for Mounjaro and about 5 to 6 days for Zepbound, according to each product's FDA label.

More detail and sources

A half-life is the time it takes for half a dose to clear. Ozempic and Wegovy are both semaglutide, so they share one; Mounjaro and Zepbound are both tirzepatide, so they do too.

The two tirzepatide labels word it slightly differently (Mounjaro: “approximately 5 days”; Zepbound: “approximately 5-6 days”), so this tool uses the middle, 5.5 days. For semaglutide it uses 7 days (Ozempic and Wegovy: “approximately 1 week”).

These are figures from groups of people in studies, and one person's can differ. The Zepbound label reports a spread of about 20% between people in how fast tirzepatide is cleared.

When does semaglutide reach steady state?

Semaglutide reaches steady state after 4 to 5 weeks of once-weekly doses, according to the Ozempic label.

More detail and sources

Steady state is the point where each week's dose replaces about what was cleared since the last one, so the level rises and falls in the same weekly pattern instead of climbing. The label's words: “Steady-state exposure is achieved following 4 to 5 weeks of once-weekly administration.” The Wegovy label gives steady-state levels but no number of weeks.

This tool's estimate agrees. On one unchanged dose, the high point after the 4th weekly shot is 94% of where it settles, and 97% after the 5th.

That is for one unchanged dose. After a dose change, the level takes about the same time again to settle at the new dose.

When does tirzepatide (Mounjaro, Zepbound) reach steady state?

Tirzepatide reaches steady state after 4 weeks of once-weekly doses, according to both the Mounjaro label and the Zepbound label.

More detail and sources

Both labels use the same sentence: “Steady-state plasma tirzepatide concentrations were achieved following 4 weeks of once weekly administration.” Steady state is the point where the level rises and falls in the same weekly pattern instead of climbing.

This tool's estimate agrees. On one unchanged dose, the high point after the 3rd weekly shot is 93% of where it settles, and 97% after the 4th.

When does the level peak after an injection?

Semaglutide reaches its highest level 1 to 3 days after an injection, and tirzepatide 8 to 72 hours after, according to their FDA labels.

More detail and sources

The Ozempic and Wegovy labels say “Maximum concentration of semaglutide is reached 1 to 3 days post dose.” The Mounjaro label says “the time to maximum plasma concentration of tirzepatide ranges from 8 to 72 hours”, and the Zepbound label gives a median of 24 hours within the same range.

The curve on this page puts the high point at the moment of the shot. That's a simplification: it counts the whole dose as present at once, because the sources Tidepath has reviewed give a half-life but not everything needed to draw absorption. Read the curve for the shape of the week, not for the hour of the peak.

Does Ozempic or Mounjaro wear off before the next shot?

The level is lower at the end of the week than at the start, but it doesn't run out: by this page's estimate, about 50% of the weekly high is left just before the next semaglutide shot, and about 41% before the next tirzepatide shot.

More detail and sources

Those figures come from the half-life alone and assume the level has settled on one unchanged dose. A real level swings less sharply than the curve, because a dose is absorbed over a day or more, not all at once.

Whether hunger or anything else changes through the week is a different question from how much medicine is left. This tool estimates the second and can't tell you the first. If the end of your week is hard, your prescriber is the person to raise it with.

Does a higher dose stay in your system longer?

No. The half-life is the same at every dose, so a higher dose clears at the same pace; there is more of it at every point, but the curve keeps its shape.

More detail and sources

The Ozempic label says semaglutide exposure “increases in a dose-proportional manner for once-weekly doses of 0.5 mg, 1 mg and 2 mg”, and both tirzepatide labels say “Tirzepatide exposure increases in a dose-proportional manner.” Double the dose, double the level, same timing.

That's why this tool never asks for your dose. For one steady weekly dose the shape is the same whatever the amount, so the curve is drawn as a share of the weekly high.

One consequence: after stopping, a larger dose takes longer to fall below any particular amount, because it starts from more. The Wegovy label's “about 5 to 7 weeks” is given for its 2.4 mg and 7.2 mg injections.

Can you get semaglutide or tirzepatide out of your system faster?

Nothing on the FDA labels speeds it up; the medicine clears at the pace its half-life sets.

More detail and sources

The labels describe both drugs as being broken down by the body over time. For an overdose they describe supportive care and a period of observation that takes the half-life into account (the Ozempic label: “taking into account the long half-life of OZEMPIC of approximately 1 week”), and no way of removing the drug sooner.

If you've taken more than you meant to, call your prescriber or the US Poison Help line, 1-800-222-1222, the number the labels give.

Is this my actual blood level?

No. It's an estimate of how much medicine is left from the doses taken, shown as a share of the weekly high. It isn't a measurement of what's in your blood.

More detail and sources

Three things are left out. Absorption: the curve counts each dose in full on shot day, when the real level peaks a day or more later. You: people clear these medicines at different rates. Your history: it draws one steady weekly dose, with no changes and no late or missed weeks.

No blood test is involved, and the curve can't tell you how you'll feel or whether a dose is right for you.

What happens to the level when my dose changes?

After a dose change, the level moves to a new weekly pattern over about the same time it took to settle at first: around 4 to 5 weeks for semaglutide and 4 weeks for tirzepatide.

More detail and sources

This page draws one unchanged dose, so it doesn't show a change. In the Tidepath app the curve is drawn from the doses you log, and dose changes are kept as a history.

When to change a dose is on your product's label and is your prescriber's decision. Nothing here suggests one.

Does the curve work for compounded semaglutide or tirzepatide?

We can't say. The curve uses half-lives from the FDA labels for Ozempic, Wegovy, Mounjaro and Zepbound, and compounded products don't have published figures of their own.

More detail and sources

The FDA puts it this way: “Compounded drugs are not FDA approved, which means the agency does not review their safety, effectiveness or quality before they are marketed” (FDA, Human Drug Compounding).

So what isn't published is how any particular compounded product is absorbed and cleared, and we don't know how well the curve fits it. The Tidepath app still logs every dose you enter, whatever the product.

Why isn't retatrutide, or a tablet like Rybelsus, on this tool?

This tool covers the once-weekly injections of semaglutide and tirzepatide only, because those have a half-life on an FDA label and a weekly schedule the curve can draw.

More detail and sources

Semaglutide tablets (Rybelsus, Ozempic tablets, Wegovy tablets) are taken every day and absorbed differently: the Wegovy label says a tablet reaches its highest level “1 hour post dose”. A weekly curve would be wrong for them.

Retatrutide is still in trials and isn't FDA-approved, so it has no label. We've left it off this tool; the peptide library covers what's been published.

For information, not medical advice. Your prescriber and your product's label come first.